| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | AH2E5UQ11Y |
| InChI Key | YWGYNGCRVZLMCS-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H17ClF2N4O3 |
| Molecular Weight | 410.81 |
| AlogP | 3.41 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 66.93 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 28.0 |
| Primary Target | |
|---|---|
| Fatty acid amide hydrolase |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials |
| Phobic Disorders | 2 | D010698 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1346528-50-4 |
| ChEMBL | CHEMBL4297294 |
| DrugBank | DB15173 |
| FDA SRS | AH2E5UQ11Y |
| Guide to Pharmacology | 9012 |
| PubChem | 54576693 |
| SureChEMBL | SCHEMBL2585102 |
| ZINC | ZINC000168658420 |